| Name | c-ABL-IN-3 |
|---|
| Description | c-ABL-IN-3 is a potent inhibitor of c-Abl. Activation of c-Abl has been implicated in various diseases, notably cancer. c-ABL-IN-3 has the potential for the research of neurodegenerative diseases (amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD) and cancer (extracted from patent WO2021048567A1, compound 50)[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Michael J. RAWLING, et al. New compounds and methods. Patent WO2021048567A1. |
| Molecular Formula | C17H11F3N4O3 |
|---|---|
| Molecular Weight | 376.29 |